Hydrogel nanoparticle encapsulated plasmid as a suitable gene delivery system by Rafiee, A. et al.
ISSN 0564–3783. Öèòîëîãèÿ è ãåíåòèêà. 2015. Ò. 49. ¹ 216
To facilitate the delivery of genetic material, the use of
appropriate carriers such as polymers is necessary. Na-
noparticles comprising of chitosan-alginate polymers were
formed through pregel preparation method. Chi/Alg nano-
particles had a mean Z-Average diameter of 161.8 nm and 
mean zeta 29.3 mV, respectively. The ability of plasmid-
complex in preventing DNA migration showed Chi/Alg 
nanoparticles have great capacity to maintain plasmid. The 
efficiency of nanoparticles for transfection of pEGFP-N1 
plasmid in the cultured HEK 293 cells was measured by 
flow cytometry. Cell viability assays indicated that nano-
particles had no toxic effect on HEK 293 cells after 4 or 
24 h. Our suitable candidate for gene delivery would be 
Alg/Chi nanoparticles.
Key words: chitosan, alginate, nanoparticle, size, transfection 
efficiency, cytotoxicity.
Introduction. The basic concept underlying gene 
therapy is the use of DNA as a pharmaceutical agent 
for curing diseases. The most currently used gene 
delivery systems are pharmaceutical nanocarriers, 
such as polymeric nanoparticles [1–3]. These bio-
degradable polymers demonstrate useful properties 
such as non-toxicity, stability and protect gene from 
degradation and etc [4]. 
Chitosan and alginate are the most commonly 
studied polymers in recent years.
Chitosan (Chi) is a cationic polymer which can 
complex with DNA via electrostatic interactions 
between anionic phosphate of DNA and amine 
groups of chitosan [5] and is successfully used as 
a non-viral gene delivery system both in vitro and 
in vivo [6, 7]
Alginate (Alg) is a kind of hydrophilic polysac-
charide [8]. Polyanion/polycation cross-linked hy-
drogel based on alginate and chitosan have gained 
much attention in recent years as carriers for local 
drug delivery [9].
Chitosan-alginate (Chi/Alg) polyionic comp-
lexes are formed through the ionic gelation via in-
teractions between the carboxyl groups of alginate 
and the amine groups of chitosan [10–13]. The 
main purpose of this study was to determine the 
size and physicochemical properties of Chi/Alg – 
pEGFP-N1 complexes. Then the potential of these 
nanoparticles in cell transfection, preventing DNA 
migration and their stability in aqueous medium 
were analyzed. The ability of plasmid-complexes 
on cell viability was also determined.
Materials and methods. Materials. Sodium algi-
nate (Sigma), Low molecular weight chitosan (Sig-
ma-Aldrich Co., Germany), L-gluthamine, Peni-
cillin, Streptomycin, Fetal bovine serum (FBS) (Bio-
sera, South Korea), PolyFect transfection reagent 
(Qiagen, Germany), 3H-thymidine (Amersham, UK).
Chitosan-alginate nanoparticles preparation for 
particle size and zeta potential analysis. Chi/Alg na-
noparticle preparation of N/P ratio of 5, CaCl2/Alg 
ratio of 0.2 %, Chi/Alg ratio of 1 and pH 5.3 was 
performed according to Gazori et al. [14].
Separate stock solutions of 1 mg/ml sodium 
alginate and calcium chloride were prepared and 
25 mg of chitosan was dissolved in 25 ml of deion-
ized water of 1 % acetic acid solution.
Subsequently, plasmid was allowed to complex 
with chitosan by vortexing 10 ng plasmid. pEGFP-
N1 was prepared with 200 ng/l concentration with 
130 l (130 g) of chitosan from the stock solution 
mentioned above. The final solution was diluted up 
to 1 ml with deionized water and then incubated 
for 30 min in room temperature. 130 l of sodium 
alginate from the stock solution was diluted with up 
to 3 ml filtered deionized water. Then in the case 
of CaCl2/Alg ratio of 0.2 %, 26 l calcium chloride 
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solution was diluted with filtered deionized water up 
to 1 ml and then added drop wise to alginate solu-
tion with the final volume of 4 ml under magnetic 
stirring condition for 10 min.
Chitosan-plasmid solution was then added drop 
wise to aforementioned solution for further 30 min 
under stirring condition at room temperature. The 
particle suspension was then centrifuged in Ami-
con® Ultra-10 (Ultracel-Sok) tube at 4000 rpm for 
30 min. 
Scanning electron microscopy (LEO1455 VP, 
10KV Cambrige) was used for particle size and 
morphological characteristic analysis. The particle 
size and zeta potential were also detected by using 
Scattering Particle Analyzer and Malvern zeta sizer 
ZS series, respectively (Malvern, Co., UK).
Gel electrophoresis of nanoparticles. According 
to the above-mentioned method with the Chi/Alg 
nanoparticles encapsulating 3 g of plasmid were 
prepared. After centrifugation at 25 °C in Amicon® 
Ultra-10 centrifuge tube, the nanoparticles were all 
incubated in aqueous medium for 1, 3, 5, 7, 9 and 
10 h. 30 l of samples were mixed with loading dye 
and were electrophoresed for 70 min run at 120 V 
on a 2 % agarose gel and the gel was photographed 
using gel documentation (Vilber lourmant, Ger-
many).
The ability of chitosan/alginate complex to pro-
tect the plasmid against chitosanase and lysozyme 
were also evaluated. Naked plasmid, chitosan/algi-
nate nanoparticle-DNA complex were treated with 
1UDNase I for 15 min at 37 °C, followed by heat 
inactivation (60 °C for 15 min) in the presence of 
25 mM EDTA. Nanoparticles were then digested 
through incubation (4 h, 37 °C) with 10 L chito-
sanase (48 U/mL in 50 mM acetate buffer pH 5.5) 
and 8 L lysozyme (0.5 U/mL in 50 mM acetate 
buffer pH 5.5) [1]. Samples were then run on a 
1 % agarose gel.
Determination of transfection efficiency by flow 
cytometry. One day before experiment, HEK 293 
cells (Pasteur Institute Cell bank of Iran) were cul-
tured in 6-well plates at 6·105 cells/well in RPMI 
supplemented with 10 % fetal bovine serum (FBS), 
2.0 mM L-gluthamine, 100 U/ml penicillin and 
100 g/ml streptomycin in 37 °C, 5 % humidified 
CO2 incubator.
On the day of transfection, the medium was 
removed and the Chi/Alg nanoparticles (26 g/l 
Chi/Alg and 2 g plasmid were used in all cases) 
Fig. 1. SEM images of
Chi/Alg nanoparticle. The 
magnification is 10000×
Fig. 2. Agarose gel electrophoresis of Chi/Alg – pEGFP-N1 
complexes. Samples were run on a 2 % gel: 1 – pEGFP-N1 
plasmid; 2 – 1-kb ladder; 3, 4, 5, 6, 7 – Chi/Alg – pEGFP-
N1 complex after 6, 5, 3, 2 and 1 h incubation
Fig. 3. Agarose gel electrophoresis of Alginate-chitosan – 
plasmid complexes. Samples were run on a 1 % gel: 1, 
7 – 1-kb ladder; 2 – pEGFP-N1 plasmid; 3 – Chi-Alg – 
pEGFP-N1; 4–6 – Chi/Alg – pEGFP-N1 following
DNAse I, chitosanase/lysozyme and chitosanase/lyso-
zyme/DNAse I digestion 
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were added to the cells. Polyfect TM (10 l) loaded 
with 10 ng pEGFP-N1 was also used as a control. 
At 48 h post-transfection, the medium was removed 
and the cells were washed with buffered saline 
(PBS). Expression of EGFP was first visualized by 
fluorescent microscopy (Leitz Germany) and the 
transfection efficiency percentage was determined 
by flow cytometry (BD, FACScan).
Cytotoxicity assay and statistical analysis. About 
1·104 cells/well HEK 293 cells were cultured in 
48-well plate in 180 l of complete growth medi-
um.  After 48 h, Chi/Alg – pEGFP-N1 nanopar-
ticles (26 g/ml) and 10 g pEGFP-N1 alone 
was added to the cells in triplicate with for 4 
and 24 h. Control cells were treated only with 
the culture medium. After exposure times, all the 
media were replaced with  fresh complete growth 
medium and the plates were incubated at 37 °C 
and 5 % CO2. One Ci/ml 3H-thymidine (Sigma, 
USA) was added to the cells for a further 16 h. 
Finally, the incorporated radioactive label activity 
was determined using a beta-counter (Wallac). Sta-
tistical significance was determined using students’ 
two-sided t-test with p < 0.05 deemed significant. 
Results and discussion. Zeta potential analysis of 
the nanoparticles. Nanoparticles of Chi/Alg had an 
average size of 161.8 nm (Fig. 1) and a strongly 
positive charge of +29.3 mV. 
According to Rieux 2006, the optimum size of 
nanoparticles that can be absorbed by enterocytes 
is 100–200 nm [15] which shows that our Chi/
Alg nanoparticles (161 nm) are also in appropriate 
size for mucosal absorption. Indeed, the majorities 
of amine groups of chitosan were protonated at 
pH 5.3 and were able to participate in electronic 
interactions with carboxyl group of alginate. Here, 
alginate can be cross-linked with the pEGFP-N1 
using polyvalent cations such as Ca2+ [16, 17]. 
Gel electrophoresis of nanoparticles. Electropho-
resis analysis was conducted to assess the stability 
of Chi/Alg – pEGFP-N1 (1, 2, 3, 5 and 6) after 
synthesis. It can be seen from Fig. 2 that pDNA 
wrapped in Chi/Alg nanoparticles was unable to 
move and remained in the loading wells even after 
6 h post synthesis.
For the purpose of evaluating the ability of 
Chi/Alg nanoparticles to protect DNA, its integrity 
was evaluated following complexation and release 
from nanoparticleas, with and without exposure to 
nucleases. Chi/Alg nanoparticles showed capacity 
of protecting DNA from enzymatic digestion (Lane 
4, 5, 6). As illustrated in Fig. 3, plasmids complexed 
with Chi/Alg nanoparticles were protected from di-
gestion, as demonstrated by the release of plasmid 
following inactivation of Dnase I and degradation 
of the nanoparticles (Lane 5, 6).  
In vitro transfection. Cellular uptake of Chi/Alg 
nanoparticles was investigated using the green fluo-
Fig. 4. Fluorescent microscopy imaging of the transfected cells as 400× magnification: 
a – the transfected HEK 293T cells showed the GFP expression for polyfect; b – GFP 
expression for Chi/Alg nanoparticles; c – the cells in visible light
Fig. 5. Cytotoxicity of alginate-chitosan-plasmid nano-
particles compared with plasmid alone and control.  The 
HEK  293 cells were cultured in 96-well plates and were 
exposed to 10 g plasmid and Chi/Alg – pEGFP-N1 
nanoparticles (26 g/ml) and negative control (medium 
cell culture (RPMI)). All data are presented as mean of 
three different measurements ± SE
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rescent protein plasmid (pEGFP-N1 – 4.7 kb) and 
were compared to polyfect transfection. Two days 
after transfection, the cells emitted the green fluo-
rescence (Fig. 4, a) under the immunofluorescent 
microscope.
Flow cytometric analysis of the transfected cells 
indicated 68 and 42 % GFP expression for polyfect 
and Chi/Alg nanoparticles, respectively. The results 
show that nanoparticles transfection and expression 
efficiency was less than polyfect/plasmid.
In fact, positive charge of amine groups of chi-
tosan can complex with negative charge of DNA 
phosphate which results in low gene transfection 
efficiency [18]. Therefore incorporation of nega-
tively charged polymer such as alginate decreases 
the strength of interaction between DNA and chito-
san. This should increase the transfection efficiency 
of the system by facilitating the release of DNA 
once the particles have been internalized by cells 
[19, 20]. However, other mechanisms of endosomal 
release such as swelling of the polymer due to its 
hydrogel effect may increase the release of pEGFP 
into the cytosol [21–23].  
Toxicity of nanoparticles. The effect of the nano-
particle-plasmid complexes on the cell viability was 
determined using cytotoxicity assay. As illustrated 
in Fig. 5, Chi/Alg nanoparticles showed no toxic-
ity and no difference compared to the control after 
4 h but had higher cell viability after 24 h (p < 
< 0.05). These results showed that alginate and chi-
tosan increased the cell proliferation by influencing 
on mitochondrial activity of the cells, stimulating 
them to proliferate [21]. 
Conclusion. In this study Chi/Alg nanoparticles 
have prepared with Chi/Alg ratio of 1, CaCl2/Alg 
ratio of 0.2 % and N/P ratio of 5 at pH 5.3. The 
great amine groups of chitosan were protonated 
at pH 5.3 and had electrostatic interactions with 
plasmid which could limit the release of pDNA by 
chitosan. Therefore Chi/Alg nanoparticles medi-
ated transfection of HEK cells, resulted in 42 % 
transfection. This shows the effect of alginate on 
reducing the strength of electrostatic interactions 
between chitosan and pDNA, resulting in better 
transfection and increasing the plasmid release. 
Moreover, an average size of Chi/Alg nanopar-
ticles was 161.8 nm with mean zeta potential of 
29.3 mV, providing characteristics desirable for 
gene delivery. Also unlike the intact pDNA, pDNA 
encapsulated in Chi/Alg nanoparticles weren’t re-
leased after 6 h which makes it a good candidate 
for pDNA protection. 
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Äëÿ îáëåã÷åíèÿ äîñòàâêè ãåíåòè÷åñêîãî ìàòåðèàëà 
íåîáõîäèìî èñïîëüçîâàíèå ïîäõîäÿùèõ íîñèòåëåé, 
òàêèõ êàê ïîëèìåðû. Íàíî÷àñòèöû, ñîñòîÿùèå èç
õèòîçàí-àëüãèíàòíûõ ïîëèìåðîâ, áûëè ïîëó÷åíû 
ìåòîäîì ïîäãîòîâêè ïðåãåëÿ. Chi/Alg íàíî÷àñòèöû 
èìåëè ñðåäíèé äèàìåòð 161.8 íì (Z-Average) è 
ñðåäíèé zeta-ïîòåíöèàë 29.3 mV. Îòñóòñòâèå ìèã-
ðàöèè ÄÍÊ âî âðåìÿ ýëåêòðîôîðåçà êîìïëåêñîâ 
ïëàçìèäû ñ íàíî÷àñòèöàìè ïîêàçàëî, ÷òî Chi/Alg 
íàíî÷àñòèöû ìîãóò óäåðæèâàòü ïëàçìèäíóþ ÄÍÊ 
âíóòðè êîìïëåêñà. Ýôôåêòèâíîñòü íàíî÷àñòèö äëÿ
òðàíñôåêöèè ïëàçìèäû pEGFP-N1 â êóëüòèâèðóå-
ìûå êëåòêè HEK 293 áûëà èçìåðåíà ñ ïîìîùüþ 
æèäêîñòíîé öèòîìåòðèè. Òåñòû íà æèçíåñïîñîá-
íîñòü êëåòîê ïîêàçàëè, ÷òî íàíî÷àñòèöû íå èìåëè 
òîêñè÷íîãî ýôôåêòà íà êëåòêè HEK 293 ÷åðåç 4 ÷ 
èëè 24 ÷. Íàíî÷àñòèöû Alg/Chi ÿâëÿþòñÿ ïîäõîäÿ-
ùèì êàíäèäàòîì äëÿ äîñòàâêè ãåíîâ. 
REFERE NCES
1. Douglas K.L., Piccirillo C.A., Tabrizian M. Effects of 
alginate inclusion on the vector properties of chi-
tosan-based nanoparticles // J. Control. Release. – 
2006. – 115, ¹ 3. – P. 354–361.
2. Alonso M.J. Nanomedicines for overcoming biologi-
cal barriers // Biomed. Pharmacother. – 2004. – 58, 
¹ 3. – P. 168–172.
3. Hama S., Akita H., Iida S. et al. Quantitative and 
mechanism-based investigation of post-nuclear de-
livery events between adenovirus and oligoplex // 
Nucl. Acids Res. – 2007. – 35. – P. 1533–1543.
4. Liu Z., Jiao Y., Wang Y. et al. Polysaccharids-based 
nanoparticles as drug delivery systems // Adv. Drug. 
Deliv. Rev. – 2008. – 60. – P. 1650–1662.
5. Kumar M.N., Muzzarelli R.A., Muzzarelli C. et al. Chi-
tosan chemistry and pharmaceutical perspectives // 
Chem. Rev. – 2004. – 104. – P. 6017–6084.
6. Kumar M., Kong X., Behera A.K. et al. Chitosan IFN-
gamma-pDNA nanoparticle (CIN) therapy for aller-
gic asthma // Genet Vaccines Ther. – 2003. – 1, 
¹ 1. – P. 3–13.
7. Chen J., Yang W.L., Li G. et al. Transfection of mEpo
gene to intestinal epithelium in vivo mediated by oral 
delivery of chitosan-DNA nanoparticles // World 
ISSN 0564–3783. Öèòîëîãèÿ è ãåíåòèêà. 2015. Ò. 49. ¹ 220
A. Rafiee, F. Riazi-rad, M.H. Alimohammadian et al.
J. Gastroenterol. – 2004. – 10, ¹ 1. – P. 112–
116.
8. Lertsutthiwong P., Noomun K., Jongaroonngamsang N. 
et al. Preparation of alginate nanocapsules contain-
ing turmeric oil // Carbohydr. Polym. – 2008. – 74, 
¹ 2. – P. 209–214.
9. Simonoska Crcarevska M., Glavas-Dodov M., Gorac-
inova K. Chitosan coated Ca-alginate microparticles 
loaded with budesonide for delivery to the inflamed 
colonic mucosa // Eur. J. Pharm. Biopharm. – 2008. – 
68, ¹ 3. – P. 565–578.
10. Mladenovska K., Cruaud O., Richomme P. et al. 5-
ASA loaded chitosan-Ca-alginate microparticles: pre-
paration and physicochemical characterization // 
Int. J. Pharm. – 2007. – 345, ¹ 1. – P. 59–69.
11. Bagre A.P., Jain K., Jain N.K. Alginate coated chi-
tosan core shell nanoparticles for oral delivery of 
enoxaparin: in vitro and in vivo assessment // Int. J. 
Biol. Macromol. – 2013. – 456, ¹ 1. – P. 31–40.
12. Motwani S.K., Chopra Sh., Talegaonkar S. et al. 
Chitosan-sodium alginate nanoparticles as submi-
croscopic reservoirs for ocular delivery: formulation, 
optimisation and in vitro characterization // Eur. J. 
Pharm. Biopharm. – 2008. – 68, ¹ 3. – P. 513–
525.
13. Yan X.L., Khor E., Lim L.Y. Chitosan-alginate films
prepared with chitosans of different molecular we-
ights // J. Biomed. Mater. Res. – 2001. – 58, 
¹ 4. – P. 358–365.
14. Gazori T., Khoshayand M.R., Azizi E. et al. Evalua-
tion of Alginate/Chitosan nanoparticles as antisense 
delivery vector : Formulation, optimization and in vi-
tro characterization // Carbohydr. Polym. – 2009. – 
77, ¹ 3. – P. 599–606.
15. Rieux A. des, Fievez V., Garinot M. et al. Nanopar-
ticle as potential oral delivery systems of proteins and 
vaccines : A mechanistic approach // J. Control. Re-
lease. – 2006. – 116, ¹ 1. – P. 1–27. 
16. Chan L.W., Lee H.Y., Heng P.W.S. Mechanisms of 
external and internal gelation and their impact on 
the functions of alginate as a coat and delivery sys-
tems // Carbohydr. Polym. – 2006. – 63, ¹ 2. – 
P. 176–187.
17. Guo R., Chen L., Cai S. et al. Novel alginate coated 
hydrophobically modified chitosan polyelectrolyte 
complex for the delivery of BSA // J. Mater. Sci. 
Mater. Med. – 2013. – 24, ¹ 9. – P. 2093–2100.
18. George M., Abraham T.E. Polyionic hydrocolloids for 
the intestinal delivery of protein drugs : Alginate and 
chitosan – a review // J. Control. Release. – 2006. – 
114, ¹ 1. – P. 1–14.
19. Duceppe N., Tabrizian M. Factors influencing the 
transfection efficiency of ultra low molecular weight 
chitosan/hyaluronic acid nanoparticles // Biomateri-
als. – 2009. – 30, ¹ 13. – P. 2625–2631.
20. Peng S.F., Yang M.J., Su C.J. et al. Effects of incor-
poration of poly(Ȗ-glutamic acid) in chitosan/DNA 
complex nanoparticles on cellular uptake and trans-
fection efficiency // Biomaterials. – 2009. – 30. – 
P. 1797–1808.
21. Dupuy B., Arien A., Birrot Minnot A. FT-IR of mem-
branes made with alginate/polylysine complexes. 
Variations with, the mannuronic or guluronic con-
tent of the polysaccharides // Artif. Cells Blood Sub-
stit. Immobil. Biotechnol. – 1994. – 22, ¹ 1. – 
P. 71–82.
22. You J.O., Peng C.A. Calcium-Alginate nanoparticles 
formed by reverse microemulsion as Gene Carriers // 
Macromol. Symp. – 2004. – 219, ¹ 1. – P. 147–
153.
23. Sonawane N.D., Szoka F.C.Jr., Verkman A.S. Chlo-
ride accumulation and swelling in endosomes en-
hances DNA transfer by polyamine-DNA polyple-
xes // J. Biol. Chem. – 2003. – 278. – P. 44826–
44831.
Received 23.07.13
